Resolute Holdings (NASDAQ: RHLD) director granted 1,452 stock options at $129.19
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Resolute Holdings Management, Inc. director Joseph J. DeAngelo received a grant of stock options on Common Stock. The award covers 1,452 options with an exercise price of $129.19 per share and no cash paid at grant. These options vest in four equal annual installments of 25% starting on June 11, 2027 and on each of the next three anniversaries, and will expire on June 11, 2036 if not exercised.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
DEANGELO JOSEPH J
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 1,452 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 1,452 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 1,452 options
Exercise price: $129.19/share
Post-grant option holdings: 1,452 options
+2 more
5 metrics
Options granted
1,452 options
Stock Option (Right to Buy) grant to director
Exercise price
$129.19/share
Conversion or exercise price for granted options
Post-grant option holdings
1,452 options
Total options held following transaction
Expiration date
June 11, 2036
Option term end for this grant
Vesting start
June 11, 2027
First 25% vesting date per footnote
Key Terms
Stock Option (Right to Buy), exercise price, vest in equal annual installments, expiration date
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion or exercise price of 129.1900 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest in equal annual installments financial
"will vest in equal annual installments of 25% each"
expiration date financial
"expiration date listed as 2036-06-11T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What insider transaction did RHLD director Joseph J. DeAngelo report?
Director Joseph J. DeAngelo reported receiving a grant of 1,452 stock options on Resolute Holdings Management, Inc. Common Stock. The grant is a compensation-related award, not an open-market purchase or sale, and increases his potential future equity exposure to the company.
What is the exercise price of the new RHLD stock options?
The granted stock options have an exercise price of $129.19 per share. This is the price DeAngelo must pay per share to convert each option into Common Stock if he chooses to exercise during the option term.
How many RHLD options does Joseph J. DeAngelo hold after this grant?
After this grant, DeAngelo holds 1,452 stock options according to the filing. These options give him the right to buy the same number of Resolute Holdings Management, Inc. Common Stock shares at the specified exercise price if they vest and he exercises.
When do Joseph J. DeAngelo’s new RHLD options vest?
The stock options vest in four equal annual installments of 25% each. Vesting starts on June 11, 2027 and continues on the first, second, and third anniversaries of that date, aligning vesting with ongoing service over several years.
When do the newly granted RHLD stock options expire?
The stock options expire on June 11, 2036 if not exercised. After that expiration date, DeAngelo will no longer be able to use these options to buy Resolute Holdings Management, Inc. Common Stock at the $129.19 exercise price.